American Alpha Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$613K Buy
21,814
+668
+3% +$17.8K 0.33% 54
2025
Q4
$527K Buy
21,146
+2,955
+16% +$74.5K 0.31% 55
2025
Q3
$464K Sell
18,191
-791
-4% -$19.5K 0.32% 50
2025
Q2
$460K Buy
18,982
+2,478
+15% +$57.8K 0.36% 45
2025
Q1
$418K Buy
+16,504
New +$432K 0.35% 56

Other funds holding PFE

American Alpha Advisors's PFE Position: Q1 2026 in Review

American Alpha Advisors increased its Pfizer (PFE) stake by 3.2% in Q1 2026, buying an estimated $17.8K and bringing the position to 21,814 shares worth $613K. The position accounts for 0.33% of the portfolio, ranked #54.

American Alpha Advisors first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • American Alpha Advisors held 21,814 shares of Pfizer worth $613K as of Q1 2026.
  • American Alpha Advisors bought 668 Pfizer shares in Q1 2026, an estimated $17.8K.
  • Pfizer made up 0.33% of American Alpha Advisors's portfolio in Q1 2026, its #54 holding.
  • American Alpha Advisors first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on American Alpha Advisors's 13F filing for Q1 2026, filed 15 May 2026.